Medical Devices & Consumables
Global Drug Eluting Guidewire Market Research Report 2026
- Feb 24, 26
- ID: 721597
- Pages: 136
- Figures: 132
- Views: 2
This report delivers a comprehensive overview of the global Drug Eluting Guidewire market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Eluting Guidewire. The Drug Eluting Guidewire market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Eluting Guidewire market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Eluting Guidewire manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
Boston Scientific
Medtronic
Svelte Medical Systems
Terumo
Micro-Port Scientific
Aachen Resonance
Biosensors International
Biotronik
Cardionovum
eucatech
Eurocor
iVascular
Laborie Medical Technologies
Lepu Medical
Spectranetics
Cook Medical
Segment by Type
Drug-coated Guidewire
Other
by Application
Coronary Intervention
Neurointervention
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Eluting Guidewire manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drug Eluting Guidewire sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Drug Eluting Guidewire market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Eluting Guidewire manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
Boston Scientific
Medtronic
Svelte Medical Systems
Terumo
Micro-Port Scientific
Aachen Resonance
Biosensors International
Biotronik
Cardionovum
eucatech
Eurocor
iVascular
Laborie Medical Technologies
Lepu Medical
Spectranetics
Cook Medical
Segment by Type
Drug-coated Guidewire
Other
by Application
Coronary Intervention
Neurointervention
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Eluting Guidewire manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drug Eluting Guidewire sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Drug Eluting Guidewire Market Overview
1.1 Product Definition
1.2 Drug Eluting Guidewire by Type
1.2.1 Global Drug Eluting Guidewire Market Value by Type: 2025 vs 2032
1.2.2 Drug-coated Guidewire
1.2.3 Other
1.3 Drug Eluting Guidewire by Application
1.3.1 Global Drug Eluting Guidewire Market Value by Application: 2025 vs 2032
1.3.2 Coronary Intervention
1.3.3 Neurointervention
1.3.4 Other
1.4 Global Drug Eluting Guidewire Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Guidewire Revenue 2021–2032
1.4.2 Global Drug Eluting Guidewire Sales 2021–2032
1.4.3 Global Drug Eluting Guidewire Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drug Eluting Guidewire Market Competition by Manufacturers
2.1 Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Eluting Guidewire Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Eluting Guidewire Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Eluting Guidewire, Product Types and Applications
2.7 Global Key Manufacturers of Drug Eluting Guidewire, Date of Entry into the Industry
2.8 Global Drug Eluting Guidewire Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Guidewire Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Eluting Guidewire Players Market Share by Revenue
2.8.3 Global Drug Eluting Guidewire Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Guidewire Market Scenario by Region
3.1 Global Drug Eluting Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Eluting Guidewire Sales by Region: 2021–2032
3.2.1 Global Drug Eluting Guidewire Sales by Region: 2021–2026
3.2.2 Global Drug Eluting Guidewire Sales by Region: 2027–2032
3.3 Global Drug Eluting Guidewire Revenue by Region: 2021–2032
3.3.1 Global Drug Eluting Guidewire Revenue by Region: 2021–2026
3.3.2 Global Drug Eluting Guidewire Revenue by Region: 2027–2032
3.4 North America Drug Eluting Guidewire Market Facts & Figures by Country
3.4.1 North America Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Eluting Guidewire Sales by Country (2021–2032)
3.4.3 North America Drug Eluting Guidewire Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Guidewire Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Eluting Guidewire Sales by Country (2021–2032)
3.5.3 Europe Drug Eluting Guidewire Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Guidewire Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Eluting Guidewire Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Eluting Guidewire Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Guidewire Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Eluting Guidewire Sales by Country (2021–2032)
3.7.3 Latin America Drug Eluting Guidewire Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Eluting Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Eluting Guidewire Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Eluting Guidewire Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Guidewire Sales by Type (2021–2032)
4.1.1 Global Drug Eluting Guidewire Sales by Type (2021–2026)
4.1.2 Global Drug Eluting Guidewire Sales by Type (2027–2032)
4.1.3 Global Drug Eluting Guidewire Sales Market Share by Type (2021–2032)
4.2 Global Drug Eluting Guidewire Revenue by Type (2021–2032)
4.2.1 Global Drug Eluting Guidewire Revenue by Type (2021–2026)
4.2.2 Global Drug Eluting Guidewire Revenue by Type (2027–2032)
4.2.3 Global Drug Eluting Guidewire Revenue Market Share by Type (2021–2032)
4.3 Global Drug Eluting Guidewire Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Eluting Guidewire Sales by Application (2021–2032)
5.1.1 Global Drug Eluting Guidewire Sales by Application (2021–2026)
5.1.2 Global Drug Eluting Guidewire Sales by Application (2027–2032)
5.1.3 Global Drug Eluting Guidewire Sales Market Share by Application (2021–2032)
5.2 Global Drug Eluting Guidewire Revenue by Application (2021–2032)
5.2.1 Global Drug Eluting Guidewire Revenue by Application (2021–2026)
5.2.2 Global Drug Eluting Guidewire Revenue by Application (2027–2032)
5.2.3 Global Drug Eluting Guidewire Revenue Market Share by Application (2021–2032)
5.3 Global Drug Eluting Guidewire Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Drug Eluting Guidewire Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boston Scientific Drug Eluting Guidewire Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Drug Eluting Guidewire Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Svelte Medical Systems
6.4.1 Svelte Medical Systems Company Information
6.4.2 Svelte Medical Systems Description and Business Overview
6.4.3 Svelte Medical Systems Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Svelte Medical Systems Drug Eluting Guidewire Product Portfolio
6.4.5 Svelte Medical Systems Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Terumo Drug Eluting Guidewire Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Micro-Port Scientific
6.6.1 Micro-Port Scientific Company Information
6.6.2 Micro-Port Scientific Description and Business Overview
6.6.3 Micro-Port Scientific Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Micro-Port Scientific Drug Eluting Guidewire Product Portfolio
6.6.5 Micro-Port Scientific Recent Developments/Updates
6.7 Aachen Resonance
6.7.1 Aachen Resonance Company Information
6.7.2 Aachen Resonance Description and Business Overview
6.7.3 Aachen Resonance Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Aachen Resonance Drug Eluting Guidewire Product Portfolio
6.7.5 Aachen Resonance Recent Developments/Updates
6.8 Biosensors International
6.8.1 Biosensors International Company Information
6.8.2 Biosensors International Description and Business Overview
6.8.3 Biosensors International Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biosensors International Drug Eluting Guidewire Product Portfolio
6.8.5 Biosensors International Recent Developments/Updates
6.9 Biotronik
6.9.1 Biotronik Company Information
6.9.2 Biotronik Description and Business Overview
6.9.3 Biotronik Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Biotronik Drug Eluting Guidewire Product Portfolio
6.9.5 Biotronik Recent Developments/Updates
6.10 Cardionovum
6.10.1 Cardionovum Company Information
6.10.2 Cardionovum Description and Business Overview
6.10.3 Cardionovum Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cardionovum Drug Eluting Guidewire Product Portfolio
6.10.5 Cardionovum Recent Developments/Updates
6.11 eucatech
6.11.1 eucatech Company Information
6.11.2 eucatech Description and Business Overview
6.11.3 eucatech Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 eucatech Drug Eluting Guidewire Product Portfolio
6.11.5 eucatech Recent Developments/Updates
6.12 Eurocor
6.12.1 Eurocor Company Information
6.12.2 Eurocor Description and Business Overview
6.12.3 Eurocor Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Eurocor Drug Eluting Guidewire Product Portfolio
6.12.5 Eurocor Recent Developments/Updates
6.13 iVascular
6.13.1 iVascular Company Information
6.13.2 iVascular Description and Business Overview
6.13.3 iVascular Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 iVascular Drug Eluting Guidewire Product Portfolio
6.13.5 iVascular Recent Developments/Updates
6.14 Laborie Medical Technologies
6.14.1 Laborie Medical Technologies Company Information
6.14.2 Laborie Medical Technologies Description and Business Overview
6.14.3 Laborie Medical Technologies Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Laborie Medical Technologies Drug Eluting Guidewire Product Portfolio
6.14.5 Laborie Medical Technologies Recent Developments/Updates
6.15 Lepu Medical
6.15.1 Lepu Medical Company Information
6.15.2 Lepu Medical Description and Business Overview
6.15.3 Lepu Medical Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Lepu Medical Drug Eluting Guidewire Product Portfolio
6.15.5 Lepu Medical Recent Developments/Updates
6.16 Spectranetics
6.16.1 Spectranetics Company Information
6.16.2 Spectranetics Description and Business Overview
6.16.3 Spectranetics Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Spectranetics Drug Eluting Guidewire Product Portfolio
6.16.5 Spectranetics Recent Developments/Updates
6.17 Cook Medical
6.17.1 Cook Medical Company Information
6.17.2 Cook Medical Description and Business Overview
6.17.3 Cook Medical Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Cook Medical Drug Eluting Guidewire Product Portfolio
6.17.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Guidewire Industry Chain Analysis
7.2 Drug Eluting Guidewire Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Guidewire Production Mode & Process Analysis
7.4 Drug Eluting Guidewire Sales and Marketing
7.4.1 Drug Eluting Guidewire Sales Channels
7.4.2 Drug Eluting Guidewire Distributors
7.5 Drug Eluting Guidewire Customer Analysis
8 Drug Eluting Guidewire Market Dynamics
8.1 Drug Eluting Guidewire Industry Trends
8.2 Drug Eluting Guidewire Market Drivers
8.3 Drug Eluting Guidewire Market Challenges
8.4 Drug Eluting Guidewire Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Drug Eluting Guidewire by Type
1.2.1 Global Drug Eluting Guidewire Market Value by Type: 2025 vs 2032
1.2.2 Drug-coated Guidewire
1.2.3 Other
1.3 Drug Eluting Guidewire by Application
1.3.1 Global Drug Eluting Guidewire Market Value by Application: 2025 vs 2032
1.3.2 Coronary Intervention
1.3.3 Neurointervention
1.3.4 Other
1.4 Global Drug Eluting Guidewire Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Guidewire Revenue 2021–2032
1.4.2 Global Drug Eluting Guidewire Sales 2021–2032
1.4.3 Global Drug Eluting Guidewire Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drug Eluting Guidewire Market Competition by Manufacturers
2.1 Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Eluting Guidewire Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Eluting Guidewire Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Eluting Guidewire, Product Types and Applications
2.7 Global Key Manufacturers of Drug Eluting Guidewire, Date of Entry into the Industry
2.8 Global Drug Eluting Guidewire Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Guidewire Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Eluting Guidewire Players Market Share by Revenue
2.8.3 Global Drug Eluting Guidewire Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Guidewire Market Scenario by Region
3.1 Global Drug Eluting Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Eluting Guidewire Sales by Region: 2021–2032
3.2.1 Global Drug Eluting Guidewire Sales by Region: 2021–2026
3.2.2 Global Drug Eluting Guidewire Sales by Region: 2027–2032
3.3 Global Drug Eluting Guidewire Revenue by Region: 2021–2032
3.3.1 Global Drug Eluting Guidewire Revenue by Region: 2021–2026
3.3.2 Global Drug Eluting Guidewire Revenue by Region: 2027–2032
3.4 North America Drug Eluting Guidewire Market Facts & Figures by Country
3.4.1 North America Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Eluting Guidewire Sales by Country (2021–2032)
3.4.3 North America Drug Eluting Guidewire Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Guidewire Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Eluting Guidewire Sales by Country (2021–2032)
3.5.3 Europe Drug Eluting Guidewire Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Guidewire Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Guidewire Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Eluting Guidewire Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Eluting Guidewire Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Eluting Guidewire Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Eluting Guidewire Sales by Country (2021–2032)
3.7.3 Latin America Drug Eluting Guidewire Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Eluting Guidewire Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Guidewire Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Eluting Guidewire Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Eluting Guidewire Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Guidewire Sales by Type (2021–2032)
4.1.1 Global Drug Eluting Guidewire Sales by Type (2021–2026)
4.1.2 Global Drug Eluting Guidewire Sales by Type (2027–2032)
4.1.3 Global Drug Eluting Guidewire Sales Market Share by Type (2021–2032)
4.2 Global Drug Eluting Guidewire Revenue by Type (2021–2032)
4.2.1 Global Drug Eluting Guidewire Revenue by Type (2021–2026)
4.2.2 Global Drug Eluting Guidewire Revenue by Type (2027–2032)
4.2.3 Global Drug Eluting Guidewire Revenue Market Share by Type (2021–2032)
4.3 Global Drug Eluting Guidewire Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Eluting Guidewire Sales by Application (2021–2032)
5.1.1 Global Drug Eluting Guidewire Sales by Application (2021–2026)
5.1.2 Global Drug Eluting Guidewire Sales by Application (2027–2032)
5.1.3 Global Drug Eluting Guidewire Sales Market Share by Application (2021–2032)
5.2 Global Drug Eluting Guidewire Revenue by Application (2021–2032)
5.2.1 Global Drug Eluting Guidewire Revenue by Application (2021–2026)
5.2.2 Global Drug Eluting Guidewire Revenue by Application (2027–2032)
5.2.3 Global Drug Eluting Guidewire Revenue Market Share by Application (2021–2032)
5.3 Global Drug Eluting Guidewire Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Drug Eluting Guidewire Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boston Scientific Drug Eluting Guidewire Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Drug Eluting Guidewire Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Svelte Medical Systems
6.4.1 Svelte Medical Systems Company Information
6.4.2 Svelte Medical Systems Description and Business Overview
6.4.3 Svelte Medical Systems Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Svelte Medical Systems Drug Eluting Guidewire Product Portfolio
6.4.5 Svelte Medical Systems Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Terumo Drug Eluting Guidewire Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Micro-Port Scientific
6.6.1 Micro-Port Scientific Company Information
6.6.2 Micro-Port Scientific Description and Business Overview
6.6.3 Micro-Port Scientific Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Micro-Port Scientific Drug Eluting Guidewire Product Portfolio
6.6.5 Micro-Port Scientific Recent Developments/Updates
6.7 Aachen Resonance
6.7.1 Aachen Resonance Company Information
6.7.2 Aachen Resonance Description and Business Overview
6.7.3 Aachen Resonance Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Aachen Resonance Drug Eluting Guidewire Product Portfolio
6.7.5 Aachen Resonance Recent Developments/Updates
6.8 Biosensors International
6.8.1 Biosensors International Company Information
6.8.2 Biosensors International Description and Business Overview
6.8.3 Biosensors International Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biosensors International Drug Eluting Guidewire Product Portfolio
6.8.5 Biosensors International Recent Developments/Updates
6.9 Biotronik
6.9.1 Biotronik Company Information
6.9.2 Biotronik Description and Business Overview
6.9.3 Biotronik Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Biotronik Drug Eluting Guidewire Product Portfolio
6.9.5 Biotronik Recent Developments/Updates
6.10 Cardionovum
6.10.1 Cardionovum Company Information
6.10.2 Cardionovum Description and Business Overview
6.10.3 Cardionovum Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cardionovum Drug Eluting Guidewire Product Portfolio
6.10.5 Cardionovum Recent Developments/Updates
6.11 eucatech
6.11.1 eucatech Company Information
6.11.2 eucatech Description and Business Overview
6.11.3 eucatech Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 eucatech Drug Eluting Guidewire Product Portfolio
6.11.5 eucatech Recent Developments/Updates
6.12 Eurocor
6.12.1 Eurocor Company Information
6.12.2 Eurocor Description and Business Overview
6.12.3 Eurocor Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Eurocor Drug Eluting Guidewire Product Portfolio
6.12.5 Eurocor Recent Developments/Updates
6.13 iVascular
6.13.1 iVascular Company Information
6.13.2 iVascular Description and Business Overview
6.13.3 iVascular Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 iVascular Drug Eluting Guidewire Product Portfolio
6.13.5 iVascular Recent Developments/Updates
6.14 Laborie Medical Technologies
6.14.1 Laborie Medical Technologies Company Information
6.14.2 Laborie Medical Technologies Description and Business Overview
6.14.3 Laborie Medical Technologies Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Laborie Medical Technologies Drug Eluting Guidewire Product Portfolio
6.14.5 Laborie Medical Technologies Recent Developments/Updates
6.15 Lepu Medical
6.15.1 Lepu Medical Company Information
6.15.2 Lepu Medical Description and Business Overview
6.15.3 Lepu Medical Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Lepu Medical Drug Eluting Guidewire Product Portfolio
6.15.5 Lepu Medical Recent Developments/Updates
6.16 Spectranetics
6.16.1 Spectranetics Company Information
6.16.2 Spectranetics Description and Business Overview
6.16.3 Spectranetics Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Spectranetics Drug Eluting Guidewire Product Portfolio
6.16.5 Spectranetics Recent Developments/Updates
6.17 Cook Medical
6.17.1 Cook Medical Company Information
6.17.2 Cook Medical Description and Business Overview
6.17.3 Cook Medical Drug Eluting Guidewire Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Cook Medical Drug Eluting Guidewire Product Portfolio
6.17.5 Cook Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Guidewire Industry Chain Analysis
7.2 Drug Eluting Guidewire Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Guidewire Production Mode & Process Analysis
7.4 Drug Eluting Guidewire Sales and Marketing
7.4.1 Drug Eluting Guidewire Sales Channels
7.4.2 Drug Eluting Guidewire Distributors
7.5 Drug Eluting Guidewire Customer Analysis
8 Drug Eluting Guidewire Market Dynamics
8.1 Drug Eluting Guidewire Industry Trends
8.2 Drug Eluting Guidewire Market Drivers
8.3 Drug Eluting Guidewire Market Challenges
8.4 Drug Eluting Guidewire Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drug Eluting Guidewire Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drug Eluting Guidewire Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drug Eluting Guidewire Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drug Eluting Guidewire Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drug Eluting Guidewire Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Guidewire, Product Types and Applications
Table 12. Global Key Manufacturers of Drug Eluting Guidewire, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Guidewire Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Guidewire Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 18. Global Drug Eluting Guidewire Sales Market Share by Region (2021–2026)
Table 19. Global Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 20. Global Drug Eluting Guidewire Sales Market Share by Region (2027–2032)
Table 21. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drug Eluting Guidewire Revenue Market Share by Region (2021–2026)
Table 23. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drug Eluting Guidewire Revenue Market Share by Region (2027–2032)
Table 25. North America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 27. North America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 28. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 32. Europe Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 33. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drug Eluting Guidewire Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 42. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 43. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drug Eluting Guidewire Sales (K Units) by Type (2021–2026)
Table 51. Global Drug Eluting Guidewire Sales (K Units) by Type (2027–2032)
Table 52. Global Drug Eluting Guidewire Sales Market Share by Type (2021–2026)
Table 53. Global Drug Eluting Guidewire Sales Market Share by Type (2027–2032)
Table 54. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drug Eluting Guidewire Revenue Market Share by Type (2021–2026)
Table 57. Global Drug Eluting Guidewire Revenue Market Share by Type (2027–2032)
Table 58. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drug Eluting Guidewire Sales (K Units) by Application (2021–2026)
Table 61. Global Drug Eluting Guidewire Sales (K Units) by Application (2027–2032)
Table 62. Global Drug Eluting Guidewire Sales Market Share by Application (2021–2026)
Table 63. Global Drug Eluting Guidewire Sales Market Share by Application (2027–2032)
Table 64. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drug Eluting Guidewire Revenue Market Share by Application (2021–2026)
Table 67. Global Drug Eluting Guidewire Revenue Market Share by Application (2027–2032)
Table 68. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Abbott Drug Eluting Guidewire Product
Table 74. Abbott Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boston Scientific Drug Eluting Guidewire Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Medtronic Drug Eluting Guidewire Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Svelte Medical Systems Company Information
Table 86. Svelte Medical Systems Description and Business Overview
Table 87. Svelte Medical Systems Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Svelte Medical Systems Drug Eluting Guidewire Product
Table 89. Svelte Medical Systems Recent Developments/Updates
Table 90. Terumo Company Information
Table 91. Terumo Description and Business Overview
Table 92. Terumo Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Terumo Drug Eluting Guidewire Product
Table 94. Terumo Recent Developments/Updates
Table 95. Micro-Port Scientific Company Information
Table 96. Micro-Port Scientific Description and Business Overview
Table 97. Micro-Port Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Micro-Port Scientific Drug Eluting Guidewire Product
Table 99. Micro-Port Scientific Recent Developments/Updates
Table 100. Aachen Resonance Company Information
Table 101. Aachen Resonance Description and Business Overview
Table 102. Aachen Resonance Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Aachen Resonance Drug Eluting Guidewire Product
Table 104. Aachen Resonance Recent Developments/Updates
Table 105. Biosensors International Company Information
Table 106. Biosensors International Description and Business Overview
Table 107. Biosensors International Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Biosensors International Drug Eluting Guidewire Product
Table 109. Biosensors International Recent Developments/Updates
Table 110. Biotronik Company Information
Table 111. Biotronik Description and Business Overview
Table 112. Biotronik Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Biotronik Drug Eluting Guidewire Product
Table 114. Biotronik Recent Developments/Updates
Table 115. Cardionovum Company Information
Table 116. Cardionovum Description and Business Overview
Table 117. Cardionovum Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cardionovum Drug Eluting Guidewire Product
Table 119. Cardionovum Recent Developments/Updates
Table 120. eucatech Company Information
Table 121. eucatech Description and Business Overview
Table 122. eucatech Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. eucatech Drug Eluting Guidewire Product
Table 124. eucatech Recent Developments/Updates
Table 125. Eurocor Company Information
Table 126. Eurocor Description and Business Overview
Table 127. Eurocor Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Eurocor Drug Eluting Guidewire Product
Table 129. Eurocor Recent Developments/Updates
Table 130. iVascular Company Information
Table 131. iVascular Description and Business Overview
Table 132. iVascular Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. iVascular Drug Eluting Guidewire Product
Table 134. iVascular Recent Developments/Updates
Table 135. Laborie Medical Technologies Company Information
Table 136. Laborie Medical Technologies Description and Business Overview
Table 137. Laborie Medical Technologies Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Laborie Medical Technologies Drug Eluting Guidewire Product
Table 139. Laborie Medical Technologies Recent Developments/Updates
Table 140. Lepu Medical Company Information
Table 141. Lepu Medical Description and Business Overview
Table 142. Lepu Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Lepu Medical Drug Eluting Guidewire Product
Table 144. Lepu Medical Recent Developments/Updates
Table 145. Spectranetics Company Information
Table 146. Spectranetics Description and Business Overview
Table 147. Spectranetics Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Spectranetics Drug Eluting Guidewire Product
Table 149. Spectranetics Recent Developments/Updates
Table 150. Cook Medical Company Information
Table 151. Cook Medical Description and Business Overview
Table 152. Cook Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Cook Medical Drug Eluting Guidewire Product
Table 154. Cook Medical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Drug Eluting Guidewire Distributors List
Table 158. Drug Eluting Guidewire Customers List
Table 159. Drug Eluting Guidewire Market Trends
Table 160. Drug Eluting Guidewire Market Drivers
Table 161. Drug Eluting Guidewire Market Challenges
Table 162. Drug Eluting Guidewire Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Eluting Guidewire
Figure 2. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drug Eluting Guidewire Market Share by Type: 2025 & 2032
Figure 4. Drug-coated Guidewire Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Drug Eluting Guidewire Market Share by Application: 2025 & 2032
Figure 8. Coronary Intervention
Figure 9. Neurointervention
Figure 10. Other
Figure 11. Global Drug Eluting Guidewire Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drug Eluting Guidewire Market Size (US$ Million), 2021–2032
Figure 13. Global Drug Eluting Guidewire Sales (K Units), 2021–2032
Figure 14. Global Drug Eluting Guidewire Average Price (US$/Unit), 2021–2032
Figure 15. Drug Eluting Guidewire Report Years Considered
Figure 16. Drug Eluting Guidewire Sales Share by Manufacturers in 2025
Figure 17. Global Drug Eluting Guidewire Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Drug Eluting Guidewire Players: Market Share by Revenue in Drug Eluting Guidewire in 2025
Figure 19. Drug Eluting Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 22. North America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 23. United States Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 26. Europe Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 27. Germany Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Drug Eluting Guidewire Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Drug Eluting Guidewire Revenue Market Share by Region (2021–2032)
Figure 34. China Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 42. Latin America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 53. Global Revenue Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 54. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 56. Global Revenue Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 57. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2032)
Figure 58. Drug Eluting Guidewire Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drug Eluting Guidewire Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drug Eluting Guidewire Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drug Eluting Guidewire Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drug Eluting Guidewire Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drug Eluting Guidewire Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drug Eluting Guidewire Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drug Eluting Guidewire, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drug Eluting Guidewire, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Guidewire, Product Types and Applications
Table 12. Global Key Manufacturers of Drug Eluting Guidewire, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Guidewire Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Guidewire Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 18. Global Drug Eluting Guidewire Sales Market Share by Region (2021–2026)
Table 19. Global Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 20. Global Drug Eluting Guidewire Sales Market Share by Region (2027–2032)
Table 21. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drug Eluting Guidewire Revenue Market Share by Region (2021–2026)
Table 23. Global Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drug Eluting Guidewire Revenue Market Share by Region (2027–2032)
Table 25. North America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 27. North America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 28. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 32. Europe Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 33. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drug Eluting Guidewire Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drug Eluting Guidewire Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drug Eluting Guidewire Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 42. Latin America Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 43. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drug Eluting Guidewire Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drug Eluting Guidewire Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drug Eluting Guidewire Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drug Eluting Guidewire Sales (K Units) by Type (2021–2026)
Table 51. Global Drug Eluting Guidewire Sales (K Units) by Type (2027–2032)
Table 52. Global Drug Eluting Guidewire Sales Market Share by Type (2021–2026)
Table 53. Global Drug Eluting Guidewire Sales Market Share by Type (2027–2032)
Table 54. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drug Eluting Guidewire Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drug Eluting Guidewire Revenue Market Share by Type (2021–2026)
Table 57. Global Drug Eluting Guidewire Revenue Market Share by Type (2027–2032)
Table 58. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drug Eluting Guidewire Sales (K Units) by Application (2021–2026)
Table 61. Global Drug Eluting Guidewire Sales (K Units) by Application (2027–2032)
Table 62. Global Drug Eluting Guidewire Sales Market Share by Application (2021–2026)
Table 63. Global Drug Eluting Guidewire Sales Market Share by Application (2027–2032)
Table 64. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drug Eluting Guidewire Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drug Eluting Guidewire Revenue Market Share by Application (2021–2026)
Table 67. Global Drug Eluting Guidewire Revenue Market Share by Application (2027–2032)
Table 68. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2027–2032)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Abbott Drug Eluting Guidewire Product
Table 74. Abbott Recent Developments/Updates
Table 75. Boston Scientific Company Information
Table 76. Boston Scientific Description and Business Overview
Table 77. Boston Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boston Scientific Drug Eluting Guidewire Product
Table 79. Boston Scientific Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Medtronic Drug Eluting Guidewire Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Svelte Medical Systems Company Information
Table 86. Svelte Medical Systems Description and Business Overview
Table 87. Svelte Medical Systems Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Svelte Medical Systems Drug Eluting Guidewire Product
Table 89. Svelte Medical Systems Recent Developments/Updates
Table 90. Terumo Company Information
Table 91. Terumo Description and Business Overview
Table 92. Terumo Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Terumo Drug Eluting Guidewire Product
Table 94. Terumo Recent Developments/Updates
Table 95. Micro-Port Scientific Company Information
Table 96. Micro-Port Scientific Description and Business Overview
Table 97. Micro-Port Scientific Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Micro-Port Scientific Drug Eluting Guidewire Product
Table 99. Micro-Port Scientific Recent Developments/Updates
Table 100. Aachen Resonance Company Information
Table 101. Aachen Resonance Description and Business Overview
Table 102. Aachen Resonance Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Aachen Resonance Drug Eluting Guidewire Product
Table 104. Aachen Resonance Recent Developments/Updates
Table 105. Biosensors International Company Information
Table 106. Biosensors International Description and Business Overview
Table 107. Biosensors International Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Biosensors International Drug Eluting Guidewire Product
Table 109. Biosensors International Recent Developments/Updates
Table 110. Biotronik Company Information
Table 111. Biotronik Description and Business Overview
Table 112. Biotronik Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Biotronik Drug Eluting Guidewire Product
Table 114. Biotronik Recent Developments/Updates
Table 115. Cardionovum Company Information
Table 116. Cardionovum Description and Business Overview
Table 117. Cardionovum Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cardionovum Drug Eluting Guidewire Product
Table 119. Cardionovum Recent Developments/Updates
Table 120. eucatech Company Information
Table 121. eucatech Description and Business Overview
Table 122. eucatech Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. eucatech Drug Eluting Guidewire Product
Table 124. eucatech Recent Developments/Updates
Table 125. Eurocor Company Information
Table 126. Eurocor Description and Business Overview
Table 127. Eurocor Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Eurocor Drug Eluting Guidewire Product
Table 129. Eurocor Recent Developments/Updates
Table 130. iVascular Company Information
Table 131. iVascular Description and Business Overview
Table 132. iVascular Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. iVascular Drug Eluting Guidewire Product
Table 134. iVascular Recent Developments/Updates
Table 135. Laborie Medical Technologies Company Information
Table 136. Laborie Medical Technologies Description and Business Overview
Table 137. Laborie Medical Technologies Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Laborie Medical Technologies Drug Eluting Guidewire Product
Table 139. Laborie Medical Technologies Recent Developments/Updates
Table 140. Lepu Medical Company Information
Table 141. Lepu Medical Description and Business Overview
Table 142. Lepu Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Lepu Medical Drug Eluting Guidewire Product
Table 144. Lepu Medical Recent Developments/Updates
Table 145. Spectranetics Company Information
Table 146. Spectranetics Description and Business Overview
Table 147. Spectranetics Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Spectranetics Drug Eluting Guidewire Product
Table 149. Spectranetics Recent Developments/Updates
Table 150. Cook Medical Company Information
Table 151. Cook Medical Description and Business Overview
Table 152. Cook Medical Drug Eluting Guidewire Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Cook Medical Drug Eluting Guidewire Product
Table 154. Cook Medical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Drug Eluting Guidewire Distributors List
Table 158. Drug Eluting Guidewire Customers List
Table 159. Drug Eluting Guidewire Market Trends
Table 160. Drug Eluting Guidewire Market Drivers
Table 161. Drug Eluting Guidewire Market Challenges
Table 162. Drug Eluting Guidewire Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Eluting Guidewire
Figure 2. Global Drug Eluting Guidewire Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drug Eluting Guidewire Market Share by Type: 2025 & 2032
Figure 4. Drug-coated Guidewire Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drug Eluting Guidewire Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Drug Eluting Guidewire Market Share by Application: 2025 & 2032
Figure 8. Coronary Intervention
Figure 9. Neurointervention
Figure 10. Other
Figure 11. Global Drug Eluting Guidewire Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Drug Eluting Guidewire Market Size (US$ Million), 2021–2032
Figure 13. Global Drug Eluting Guidewire Sales (K Units), 2021–2032
Figure 14. Global Drug Eluting Guidewire Average Price (US$/Unit), 2021–2032
Figure 15. Drug Eluting Guidewire Report Years Considered
Figure 16. Drug Eluting Guidewire Sales Share by Manufacturers in 2025
Figure 17. Global Drug Eluting Guidewire Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Drug Eluting Guidewire Players: Market Share by Revenue in Drug Eluting Guidewire in 2025
Figure 19. Drug Eluting Guidewire Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Drug Eluting Guidewire Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 22. North America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 23. United States Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 26. Europe Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 27. Germany Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Drug Eluting Guidewire Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Drug Eluting Guidewire Revenue Market Share by Region (2021–2032)
Figure 34. China Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 42. Latin America Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Drug Eluting Guidewire Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Drug Eluting Guidewire Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Drug Eluting Guidewire Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 53. Global Revenue Market Share of Drug Eluting Guidewire by Type (2021–2032)
Figure 54. Global Drug Eluting Guidewire Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 56. Global Revenue Market Share of Drug Eluting Guidewire by Application (2021–2032)
Figure 57. Global Drug Eluting Guidewire Price (US$/Unit) by Application (2021–2032)
Figure 58. Drug Eluting Guidewire Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232